From research to regulated: Challenges in transferring methods

Bioanalysis

Volumn 1, Issue 2, 2009, Pages 285-291

  Chowdhury, Ferdousi ^a   Williams, Anthony ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHEMICAL ANALYSIS; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; METHODOLOGY; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSLATIONAL RESEARCH;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CHEMISTRY TECHNIQUES, ANALYTICAL; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, MEDICAL; TRANSLATIONAL RESEARCH;

EID: 78649689433     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.51     Document Type: Article

References (12)

1. DeSilva B, Smith W, Weiner R et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20(11), 1885-1900 (2003).
2. Mire-Sluis AR, Barrett YC, Devanarayan V et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J. Immunol. Methods 289(1), 1-16 (2004).
3. Shah V P, Midha KK, Findlay JW et al. Bioanalytical method validation- A revisit with a decade of progress. Pharm. Res. 17(12), 1551-1557 (2000).
4. Lee JW, Devanarayan V, Barrett YC et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23(2), 312-328 (2006).
5. Cummings J, Ward TH, Greystoke A et al. Biomarker method validation in anticancer drug development. Br. J. Pharmacol. 153(4), 646-656 (2008).
6. Shah VP. The history of bioanalytical method validation and regulation: evolution of a guidance document on bioanalytical methods validation. AAPS J. 9, E43-E47 (2007).
7. Miller KJ, Bowsher RR, Celniker A et al. Workshop on bioanalytical methods validation for macromolecules: summary report. Pharm. Res. 18(9), 1373-1383 (2001).
8. Khan SS, Smith MS, Reda D et al. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin. Cytom. 61(1), 35-39 (2004).
9. Stenman UH. Immunoassay standardization: is it possible, who is responsible, who is capable? Clin. Chem. 47(5), 815-820 (2001).
10. Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, luminex and mesoscale discovery for human cytokine profling. J. Immunol. Methods 340(1), 55-64 (2009).
11. Amundsen LK, Siren H. Immunoaffnity CE in clinical ana lysis of body fuids and tissues. Electrophoresis 28(1-2), 99-113 (2007).
12. Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43(1), 155-163 (2000).